Review



cleaved caspase 9  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc cleaved caspase 9
    Cleaved Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 378 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase 9/product/Cell Signaling Technology Inc
    Average 96 stars, based on 378 article reviews
    cleaved caspase 9 - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    93
    DSMZ burkholderia plantarii dsm 9509
    Burkholderia Plantarii Dsm 9509, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/burkholderia plantarii dsm 9509/product/DSMZ
    Average 93 stars, based on 1 article reviews
    burkholderia plantarii dsm 9509 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cleaved caspase 9
    Cleaved Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase 9/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    cleaved caspase 9 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cleaved caspase9
    High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved <t>caspase9</t> and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment
    Cleaved Caspase9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase9/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    cleaved caspase9 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Berthold Technologies junior lb 9509 luminometer
    High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved <t>caspase9</t> and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment
    Junior Lb 9509 Luminometer, supplied by Berthold Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/junior lb 9509 luminometer/product/Berthold Technologies
    Average 90 stars, based on 1 article reviews
    junior lb 9509 luminometer - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cleaved caspases 9
    High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved <t>caspase9</t> and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment
    Cleaved Caspases 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspases 9/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    cleaved caspases 9 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Berthold Technologies portable high sensitivity chemiluminometer junior lb 9509
    High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved <t>caspase9</t> and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment
    Portable High Sensitivity Chemiluminometer Junior Lb 9509, supplied by Berthold Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/portable high sensitivity chemiluminometer junior lb 9509/product/Berthold Technologies
    Average 90 stars, based on 1 article reviews
    portable high sensitivity chemiluminometer junior lb 9509 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti cleaved caspase 9
    High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved <t>caspase9</t> and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment
    Rabbit Anti Cleaved Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti cleaved caspase 9/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti cleaved caspase 9 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved caspase9 and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment

    Journal: Molecular Medicine

    Article Title: Overexpression of c-Myc triggers p62 aggregation-mediated mitochondrial mitophagy in cabozantinib resistance of hepatocellular carcinoma

    doi: 10.1186/s10020-025-01263-w

    Figure Lengend Snippet: High Expression of c-Myc Promotes Cabozantinib Resistance in Liver Cancer Cells. A Differential expression pathway heatmap of cells with or without cabozantinib resistance ( GSE174770 ). B Detection of c-Myc expression in subcutaneous tumor models established with resistant and sensitive liver cancer cell lines. C Cell viability assay using CCK-8 method after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. D Western blot analysis of BAX, BCL2, CYTC, Cleaved caspase9 and Cleaved caspase3. E-F Apoptosis detection using flow cytometry after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. F Dose-response analysis of cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. The IC50 of SNU-368-S and SNU-739-S increased from 7.25 µM and 6.23 µM to 12.49 µM and 10.60 µM, respectively, while the IC50 of SNU-368-R and SNU-739-R decreased from 17.66 µM and 14.84 µM to 10.52 µM and 9.14 µM, respectively. G Caspase 3/7 Activity Apoptosis Assay to detect caspase3 activity in cells after overexpressing c-Myc in cabozantinib-sensitive cells and knocking down c-Myc in resistant cells. H Construction of subcutaneous tumor models in mice and administration schedule. I-J Images of subcutaneous tumor and changes in tumor volume. K Construction of c-Myc-induced orthotopic liver cancer model using the Sleeping Beauty system, L Gross images of the c-Myc-induced in situ liver cancer mouse model and its appearance after cabozantinib treatment. M-O Statistical analysis of mouse mortality rate, liver/body ratio and tumor number after cabozantinib treatment

    Article Snippet: Cleaved caspase9 , CST (#9509) , 1:1000.

    Techniques: Expressing, Quantitative Proteomics, Viability Assay, CCK-8 Assay, Western Blot, Flow Cytometry, Activity Assay, Apoptosis Assay, In Situ